Iain Dillingham
Software Developer
Iain is a software developer, working on OpenSAFELY. Prior to joining the Bennett Institute, he worked in several data science and software development teams, with a focus on quantifying reputational and geopolitical risk. Iain has a PhD and MSc in Geographic Information Science, and a BA in Geography.
Papers by Iain Dillingham
- The impact of COVID-19 on medication reviews in English primary care
- Measuring BMI in 22 million patients in England
- OpenSAFELY: a platform for analysing electronic health records designed for reproducible research
- Trends in inequalities in avoidable hospitalisations across the COVID-19 pandemic
- Consistency, completeness and external validity of ethnicity recording in NHS primary care records
- Group A streptococcal cases and treatments during the COVID-19 pandemic and 2022 outbreak
- The impact of COVID-19 on medication reviews in English primary care
- Impact of the COVID-19 pandemic on antipsychotic prescribing in individuals with autism, dementia, learning disability, serious mental illness or living in a care home
- Fit notes associated with COVID-19 in 24 million patients’ primary care records
- Challenges in Estimating the Effectiveness of 2 Doses of COVID-19 Vaccine Beyond 6 Months in England
- Impact of COVID-19 on recorded blood pressure screening and hypertension management in England
- Eleven key measures for monitoring general practice clinical activity during COVID-19
- Changes in medication safety indicators in England throughout the covid-19 pandemic using OpenSAFELY
- Changes in COVID-19-related mortality across key demographic and clinical subgroups in England from 2020 to 2022
- Trends, variation, and clinical characteristics of recipients of antiviral drugs and neutralising monoclonal antibodies for covid-19 in community settings
- Challenges in estimating waning effectiveness of two doses of BNT162b2 and ChAdOx1 COVID-19 vaccines beyond six months
- Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose
- Effectiveness of BNT162b2 booster doses in England